It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The aims of this study were to characterize new SARS-CoV-2 genomes sampled all over Italy and to reconstruct the origin and the evolutionary dynamics in Italy and Europe between February and June 2020. The cluster analysis showed only small clusters including < 80 Italian isolates, while most of the Italian strains were intermixed in the whole tree. Pure Italian clusters were observed mainly after the lockdown and distancing measures were adopted. Lineage B and B.1 spread between late January and early February 2020, from China to Veneto and Lombardy, respectively. Lineage B.1.1 (20B) most probably evolved within Italy and spread from central to south Italian regions, and to European countries. The lineage B.1.1.1 (20D) developed most probably in other European countries entering Italy only in the second half of March and remained localized in Piedmont until June 2020. In conclusion, within the limitations of phylogeographical reconstruction, the estimated ancestral scenario suggests an important role of China and Italy in the widespread diffusion of the D614G variant in Europe in the early phase of the pandemic and more dispersed exchanges involving several European countries from the second half of March 2020.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Milan, Department of Biomedical and Clinical Sciences Luigi Sacco, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822); University of Milan, Pediatric Clinical Research Center Fondazione Romeo ed Enrica Invernizzi, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
2 University of Milan, Department of Biomedical and Clinical Sciences Luigi Sacco, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
3 University of Padova, Department of Molecular Medicine, Padua, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); CRIBI Biotech Center, University of Padova, Padua, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
4 Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna, Risk Analyses and Genomic Epidemiology Unit, Parma, Italy (GRID:grid.419583.2) (ISNI:0000 0004 1757 1598)
5 Virology Unit, Polytechnic University of Marche, Department of Biomedical Sciences and Public Health, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210)
6 Amedeo di Savoia, ASL Città di Torino, Laboratory of Microbiology and Virology, Torino, Italy (GRID:grid.7010.6)
7 Hygiene Unit, IRCCS AOU San Martino-IST, Genoa, Italy (GRID:grid.410345.7) (ISNI:0000 0004 1756 7871)
8 Guglielmo da Saliceto Hospital, AUSL Piacenza, UOC of Infectious Diseases, Department of Oncology and Hematology, Piacenza, Italy (GRID:grid.410345.7)
9 University of Sassari, Infectious and Tropical Disease Clinic, Department of Medical, Surgical and Experimental Sciences, Sassari, Italy (GRID:grid.11450.31) (ISNI:0000 0001 2097 9138)
10 University of Messina, Unit of Infectious Diseases, Department of Experimental and Clinical Medicine, Messina, Italy (GRID:grid.10438.3e) (ISNI:0000 0001 2178 8421)
11 University Hospital Policlinico Umberto I, Sapienza University of Rome, Department of Molecular Medicine, Rome, Italy (GRID:grid.7841.a)
12 Tor Vergata University, Infectious Diseases, Rome, Italy (GRID:grid.6530.0) (ISNI:0000 0001 2300 0941)
13 University of Bari, Infectious Diseases Unit, Bari, Italy (GRID:grid.7644.1) (ISNI:0000 0001 0120 3326)
14 ASST Papa Giovanni XXIII, Microbiology and Virology Laboratory, Bergamo, Italy (GRID:grid.460094.f) (ISNI:0000 0004 1757 8431)
15 University of Campania “Luigi Vanvitelli”, Department of Mental Health and Public Medicine, Naples, Italy (GRID:grid.9841.4) (ISNI:0000 0001 2200 8888)
16 “Santa Maria della Misericordia” Hospital, University of Perugia, Department of Medicine and Surgery, Clinic of Infectious Diseases, Perugia, Italy (GRID:grid.9027.c) (ISNI:0000 0004 1757 3630)
17 University of Siena, Department of Medical Biotechnologies, Siena, Italy (GRID:grid.9024.f) (ISNI:0000 0004 1757 4641)
18 Intesa San Paolo Innovation Center-AI LAB, Turin, Italy (GRID:grid.9024.f)
19 IRCCS Ospedale San Raffaele, Center for Omics Sciences, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884); IRCCS Ospedale San Raffaele, Division of Experimental Oncology, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884)
20 IRCCS Ospedale San Raffaele, Division of Immunology, Transplantation and Infectious Disease, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884)
21 University of Genoa, Department of Health Sciences (DISSAL), Genoa, Italy (GRID:grid.5606.5) (ISNI:0000 0001 2151 3065)
22 Guglielmo da Saliceto Hospital, AUSL Piacenza, UOC of Microbiology, Department of Clinical Pathology, Piacenza, Italy (GRID:grid.5606.5)
23 University Hospital Policlinico Umberto I, Sapienza University of Rome, Department of Public Health and Infectious Diseases, Rome, Italy (GRID:grid.7841.a)
24 Padua University Hospital, Microbiology and Virology Diagnostic Unit, Padua, Italy (GRID:grid.411474.3) (ISNI:0000 0004 1760 2630); Imperial College London, Department of Life Science, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
25 University of Milan, Department of Biomedical and Clinical Sciences Luigi Sacco, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822); University of Milan, Pediatric Clinical Research Center Fondazione Romeo ed Enrica Invernizzi, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822); University of Milan, CRC-Coordinated Research Center “EpiSoMI”, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
26 University of Padova, Department of Molecular Medicine, Padua, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
27 San Michele All’Adige, Research and Innovation Centre, Fondazione Edmund Mach, Trento, Italy (GRID:grid.424414.3) (ISNI:0000 0004 1755 6224)
28 University of Studies of Torino, Department of Veterinary Science, Turin, Italy (GRID:grid.424414.3)
29 Emerging Bacterial Pathogens Unit IRCCS Ospedale San Raffaele, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884)
30 Guglielmo da Saliceto Hospital, AUSL Piacenza, UOC of Infectious Diseases, Department of Oncology and Hematology, Piacenza, Italy (GRID:grid.5606.5)
31 University of Sassari, Department of Biomedical Science, Sassari, Italy (GRID:grid.11450.31) (ISNI:0000 0001 2097 9138)
32 University of Messina, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi” Division of Microbiology, Messina, Italy (GRID:grid.10438.3e) (ISNI:0000 0001 2178 8421)
33 AORN S. Anna E S. Sebastiano Caserta, Caserta, Italy (GRID:grid.9841.4)
34 INTESA s.p.a., Prevention and Protection Service, Milan, Italy (GRID:grid.9024.f)




